STAT News1 min read
Biotech investors’ plea to Trump, and a busy M&A...
How has the FDA's recent decisions on rare disease drugs affected investment trends? Why is Eli Lilly getting into sleep medicine? Find out on this week's episode of "The Readout…
Read original on statnews.com0
0Related
STAT News
STAT+: AI drug developer Insilico Medicine and...
Lilly has signed a deal with AI drug developer Insilico that’s worth $115 million up front and approximately $2.75 billion in biobucks
0
0STAT News
7 big challenges for the next CDC director
Whoever takes over the CDC next will face immediate and enormous challenges. Here are a few.
0
0STAT News
Opinion: Remembering public health pioneer Barry...
Marc Lipsitch and Yonatan Grad pay tribute to their former colleague and mentor Barry R. Bloom.
0
0Get the 10 best reads every Sunday
Curated by AI, voted by readers. Free forever.
Liked this? Start your own feed.
Comment
Sign in to join the discussion.
Loading comments…